JNJ

Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout
Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout
Investors Business Daily
JNJ
MeiraGTx
M&A
Flag link:
U.S. FDA labels J&J surgical staplers' recall as severe
U.S. FDA labels J&J surgical staplers' recall as severe
Yahoo/Reuters
devices
FDA
JNJ
recalls
surgical stapler
Flag link:
Preclinical data on MD Anderson Cancer Center-developed drug offers hope for Imbruvica-resistant mantle cell lymphoma patients
Preclinical data on MD Anderson Cancer Center-developed drug offers hope for Imbruvica-resistant mantle cell lymphoma patients
Endpoints
Imbruvica
non-Hodgkin lymphoma
mantle cell lymphoma
JNJ
MD Anderson Cancer Center
Flag link:
J&J's Ethicon Spends $400M for Takeda’s Fibrin Sealant Patch
J&J's Ethicon Spends $400M for Takeda’s Fibrin Sealant Patch
Medical Devices and Diagnostics Industry
JNJ
Ethicon
M&A
Takeda
Fibrin Sealant Patch
surgical patch
TachoSil
devices
Flag link:
J&J Takes Hits on Talc Lawsuit, Settles Xarelto Suit, Faces Pricing Criticism
J&J Takes Hits on Talc Lawsuit, Settles Xarelto Suit, Faces Pricing Criticism
BioSpace
JNJ
Xarelto
drug pricing
Flag link:
ICER chastises J&J for overpricing depression drug esketamine ‘where there is such need for treatment’
ICER chastises J&J for overpricing depression drug esketamine ‘where there is such need for treatment’
Endpoints
JNJ
drug pricing
antidepressants
esketamine
Spravato
ICER
Flag link:
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
Researchers warn about gangrene cases in patients on SGLT2 diabetes drugs
Fierce Pharma
gangrene
diabetes
JNJ
Invokana
AstraZeneca
Farxiga
Eli Lilly
Boehringer Ingelheim
Jardiance
Flag link:
J&J agrees to pay about $1 billion to resolve hip implant lawsuits
J&J agrees to pay about $1 billion to resolve hip implant lawsuits
Reuters
JNJ
DePuy Synthes
Pinnacle Hip
metal-on-metal hip implants
devices
Flag link:
Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises
Watch out AbbVie and J&J, AstraZeneca just took another big swing at one of your star cancer drug franchises
Endpoints
AstraZeneca
Calquence
clinical trials
chronic lymphocytic leukemia
AbbVie
JNJ
Imbruvica
Flag link:
Where Will Johnson & Johnson Be in 10 Years?
Where Will Johnson & Johnson Be in 10 Years?
Motley Fool
JNJ
Flag link:
Marketing J&J eyes prostate cancer boost as FDA accepts Erleada for real-time review
Marketing J&J eyes prostate cancer boost as FDA accepts Erleada for real-time review
Fierce Pharma
JNJ
Erleada
FDA
prostate cancer
metastatic castration-resistant prostate cancer
Flag link:
J&J's quest to detect lung cancer before it emerges
J&J's quest to detect lung cancer before it emerges
Fierce Biotech
JNJ
smoking
lung cancer
MRNA
biomarkers
Flag link:
Arrowhead starts triple-combo hepatitis B test, triggering J&J payday
Arrowhead starts triple-combo hepatitis B test, triggering J&J payday
Fierce Biotech
Arrowhead Pharmaceuticals
JNJ
clinical trials
hepatitis B
ARO-HBV
Flag link:
What does the past generation of failure in Alzheimer’s R&D look like in one slide?
What does the past generation of failure in Alzheimer’s R&D look like in one slide?
Endpoints
R&D
Alzheimer's disease
amyloid beta
Eli Lilly
Pfizer
JNJ
Flag link:
Investors to AbbVie, J&J, Merck and more: Fork over info on pricing and executive pay
Investors to AbbVie, J&J, Merck and more: Fork over info on pricing and executive pay
Fierce Pharma
AbbVie
Celgene
JNJ
Merck
Pfizer
Vertex Pharmaceuticals
investors
executive pay
Flag link:
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Bayer, J&J's Xarelto scripts stagnate as discounts, competition pile up
Fierce Pharma
Bayer
JNJ
Xarelto
bloodthinners
Bristol-Myers Squibb
Pfizer
Eliquis
Flag link:
Most people pay less than $5 per month for the drug. But some pay $11,002
Most people pay less than $5 per month for the drug. But some pay $11,002
Stat
JNJ
Janssen
Stelara
drug pricing
Flag link:
Johnson & Johnson Rises After Topping First-Quarter Earnings Forecasts
Johnson & Johnson Rises After Topping First-Quarter Earnings Forecasts
TheStreet.com
JNJ
earnings
Flag link:
J&J, Merck and Pfizer spent tax savings on investor payouts, not R&D: Oxfam
J&J, Merck and Pfizer spent tax savings on investor payouts, not R&D: Oxfam
Fierce Pharma
taxes
tax cuts
investors
R&D
Merck
JNJ
Pfizer
Flag link:
Forward Guidance Will Make or Break JNJ Earnings
Forward Guidance Will Make or Break JNJ Earnings
NASDAQ
JNJ
earnings
Flag link:

Pages